ONE-WAYDated event · through FY2027-H1
Collaboration in the in vitro diagnostics business and conversion into an equity-method affiliate through the acquisition of shares in TAUNS Laboratories,Inc.
An individual transaction involving the acquisition of shares in TAUNS Laboratories,Inc., a company engaged in in vitro diagnostics and related products, to make it an equity-method affiliate, with collaboration in sales networks for medical institutions and testing facilities, gene extraction and analysis technologies, research and development, and manufacturing and sales.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.
PeriodFY2027-H1 →Last written FY2027-H1
Directionhelps1 helps · 0 hurts · 0 flat